Clinical Trial Update: To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on inavolisib as a single agent and in combination with endocrine and targeted therapies for breast cancer and solid tumors; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumor

Drugs mentioned

• Inavolisib (Inavolisib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer, Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING